Literature DB >> 20473742

Effects of Tongguan Capsule on post-myocardial infarction ventricular remodeling and cardiac function in rats.

Bo-jun Chen1, Jing-xi Feng, Xue-xu Su, Li-qin Meng, Zhi-shang Li, Yan-li Gao, Xiao-li Xia.   

Abstract

OBJECTIVE: To observe the effects of Tongguan Capsule (TGC) on post-myocardial infarction ventricular remodeling and heart function in rats.
METHODS: A rat model of acute myocardial infarction (AMI) was established by coronary ligation. Experimental rats were randomized to 4 groups including three model groups (Group A: captopril 5 mg/kg * day, n=7; Group B: TGC 10 g/kg * day, n=7; and Group C: placebo, n=8), and a sham-control group (Group D: blank control, n=6). Animals were treated for 4 weeks. The cardiac function of rats was assessed at the end of the experiment based on left ventricular ejection fraction (LVEF) and left ventricular short axis fractional shortening (LVFS) detected by colored echocardiography; meanwhile, the condition of ventricular remodeling was observed through the levels of left ventricular mass (LVM), plasma aldosterone (ALD), myocardial angiotensin II (Ang II) and myocardial collagen measurements.
RESULTS: At the end of the experiment, LVEF and LVFS in Group A and B were improved significantly, while those in Group C were unchanged, the LVEF in Group A, B, C, and D was 0.57+/-0.46, 0.61+/-0.08, 0.36+/-0.55 and 0.76+/-0.02, respectively; and their LVFS was 0.31+/-0.52, 0.34+/-0.04, 0.23+/-0.57 and 0.45+/-0.03, respectively. The difference was statistically significant when comparing the two indexes in Group A and B with those in Group C and D (P<0.05). LVM, levels of plasma ALD and myocardial Ang II were lower in Group A and B than in Group C, but a comparison between Group A and B showed an insignificant difference in lowering LVM and ALD, while the lowering of Ang II was more significant in Group B than in Group A (754.7 +/- 18.7 pg/mL vs 952.6+/-17.6 pg/mL, P<0.05). Morphological examination showed that in Group A and B the swollen myocardial cells had shrunk, with regularly arranged myocardial fibers and decreased collagen proliferation, but the improvements in Group B were more significant.
CONCLUSION: TGC could markedly improve the post-infarction ventricular remodeling and cardiac function in rats, showing that the efficacy was better than or equal to that of captopril.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473742     DOI: 10.1007/s11655-010-0157-1

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  12 in total

1.  Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction.

Authors:  M A Pfeffer; G A Lamas; D E Vaughan; A F Parisi; E Braunwald
Journal:  N Engl J Med       Date:  1988-07-14       Impact factor: 91.245

2.  Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction.

Authors:  N Sharpe; J Murphy; H Smith; S Hannan
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

3.  Determination of right ventricular structure and function in normoxic and hypoxic mice: a transesophageal echocardiographic study.

Authors:  M Scherrer-Crosbie; W Steudel; P R Hunziker; G P Foster; L Garrido; N Liel-Cohen; W M Zapol; M H Picard
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

4.  Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators.

Authors: 
Journal:  Lancet       Date:  1993-10-02       Impact factor: 79.321

5.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Authors:  M A Pfeffer; E Braunwald; L A Moyé; L Basta; E J Brown; T E Cuddy; B R Davis; E M Geltman; S Goldman; G C Flaker
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

6.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.

Authors:  H D White; R M Norris; M A Brown; P W Brandt; R M Whitlock; C J Wild
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

Review 7.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

8.  Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat.

Authors:  S E Litwin; S E Katz; J P Morgan; P S Douglas
Journal:  Circulation       Date:  1994-01       Impact factor: 29.690

9.  Evidence for an angiotensin II-like material and for a rapid metabolism of angiotensin II in the rat brain.

Authors:  G Simonnet; A Carayon; M Alard; F Cesselin; A Lagoguey
Journal:  Brain Res       Date:  1984-06-18       Impact factor: 3.252

10.  Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution.

Authors:  M C Fishbein; D Maclean; P R Maroko
Journal:  Am J Pathol       Date:  1978-01       Impact factor: 4.307

View more
  3 in total

Review 1.  Insights of Chinese medicine on ventricular remodeling: Multiple-targets, individualized-treatment.

Authors:  Dan-Cai Fan; Jian-Yong Qi; Min-Zhou Zhang
Journal:  Chin J Integr Med       Date:  2017-09-02       Impact factor: 1.978

2.  Tongguan Capsule Protects against Myocardial Ischemia and Reperfusion Injury in Mice.

Authors:  Jianyong Qi; Juan Yu; Lei Wang; Liheng Guo; Shiyu Ma; Donghui Huang; Miao Zhou; Jiashin Wu; Minzhou Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-01       Impact factor: 2.629

3.  Tongguan capsule-derived herb reduces susceptibility to atrial fibrillation by inhibiting left atrial fibrosis via modulating cardiac fibroblasts.

Authors:  Shiyu Ma; Jin Ma; Liheng Guo; Junqi Bai; Shuai Mao; Minzhou Zhang
Journal:  J Cell Mol Med       Date:  2018-11-19       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.